
Knee Cartilage Repair Market Report 2026
Global Outlook – By Device Type (Implants, Osteotomy, Bone Grafts, Arthroscopy, Resurfacing, Arthrodesis, Other Devices), By Application (Arthroscopic Chondroplasty, Autologous Chondrocyte Implantation, Cell-Based Cartilage Resurfacing, Osteochondral Grafts Transplantation, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics) - Market Size, Trends, And Global Forecast 2026-2035
Knee Cartilage Repair Market Overview
• Knee Cartilage Repair market size has reached to $3.1 billion in 2025 • Expected to grow to $4.16 billion in 2030 at a compound annual growth rate (CAGR) of 5.9% • Growth Driver: Rise In Sports-Related Injuries Fueling The Growth Of The Market Due To Active Lifestyles • Market Trend: Innovative Knee Cartilage Repair Implants Transforming The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Knee Cartilage Repair Market?
Knee cartilage repair involves medical treatments designed to address damage to the cartilage in the knee joint. This cartilage is a smooth, flexible tissue that enables the bones in the joint to move smoothly without friction. When it becomes damaged whether due to injury, wear and tear (such as osteoarthritis), or other factors it can result in pain, stiffness, swelling, and decreased mobility. The main device types of knee cartilage repair are implants, osteotomy, bone grafts, arthroscopy, resurfacing, arthrodesis, and others. Implants are artificial components that are surgically placed into the knee joint to replace lost or injured cartilage. These find application in arthroscopic chondroplasty, autologous chondrocyte implantation, cell-based cartilage resurfacing, osteochondral graft transplantation, and others and are used by several end users, mainly hospitals, ambulatory surgical centers, and orthopedic clinics.
What Is The Knee Cartilage Repair Market Size and Share 2026?
The knee cartilage repair market size has grown strongly in recent years. It will grow from $3.1 billion in 2025 to $3.31 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing prevalence of osteoarthritis, rising incidence of knee injuries among athletes, established use of arthroscopic procedures, growing demand for joint preservation techniques, expansion of orthopedic surgical infrastructure.What Is The Knee Cartilage Repair Market Growth Forecast?
The knee cartilage repair market size is expected to see strong growth in the next few years. It will grow to $4.16 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to aging population with cartilage degeneration, increasing adoption of regenerative medicine, rising demand for motion-preserving knee treatments, advancements in biomaterials and implants, growing awareness of early cartilage intervention. Major trends in the forecast period include rising adoption of minimally invasive cartilage repair procedures, growing use of cell-based and regenerative therapies, increasing preference for arthroscopic knee cartilage treatments, expansion of sports injury–related cartilage repair surgeries, improved clinical outcomes with advanced implant materials.Global Knee Cartilage Repair Market Segmentation
1) By Device Type: Implants, Osteotomy, Bone Grafts, Arthroscopy, Resurfacing, Arthrodesis, Other Devices 2) By Application: Arthroscopic Chondroplasty, Autologous Chondrocyte Implantation, Cell-Based Cartilage Resurfacing, Osteochondral Grafts Transplantation, Other Applications 3) By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics Subsegments: 1) By Implants: Metallic Implants, Polymeric Implants, Ceramic Implants 2) By Osteotomy: High Tibial Osteotomy, Distal Femoral Osteotomy 3) By Bone Grafts: Autografts, Allografts, Synthetic Bone Grafts 4) By Arthroscopy: Diagnostic Arthroscopy, Surgical Arthroscopy 5) By Resurfacing: Partial Knee Resurfacing, Total Knee Resurfacing 6) By Arthrodesis: Patella Arthrodesis, Femoral Arthrodesis, Tibial Arthrodesis 7) By Other Devices: Cartilage Scaffolds, Growth Factors, Stem Cell-Based DevicesWhat Is The Driver Of The Knee Cartilage Repair Market?
The rising incidence of sports-related injuries is expected to propel the growth of the knee cartilage repair market going forward. Sports-related injuries refer to physical harm sustained during athletic or recreational activities, often caused by repetitive stress, overuse, or trauma, and they can result in joint pain, cartilage damage, and limited mobility. The increase in such injuries is attributed to higher participation in sports, more intense training regimens, and insufficient preventive measures. Knee cartilage repair supports recovery from these injuries by restoring damaged cartilage, reducing pain, and enabling a faster return to physical activity while lowering the risk of long-term joint degeneration. For instance, in July 2025, according to the Australian Institute of Health and Welfare, an Australia-based national government health statistics agency, more than 62,100 sports-related injury hospitalisations were recorded in Australia in 2023–24, with males accounting for around 70% of cases (about 43,800) and females representing nearly 30% (around 18,300). Therefore, the rising incidence of sports-related injuries is driving the growth of the knee cartilage repair industry.Key Players In The Global Knee Cartilage Repair Market
Major companies operating in the knee cartilage repair market are Stryker Corporation, B. Braun Melsungen AG, DePuy Synthes, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Integra LifeSciences, Bioventus LLC, MTF Biologics, MiMedx Group Inc., Moximed Inc., Vericel Corporation, Anika Therapeutics Inc., SeaSpine Holdings Corporation, LifeNet Health, ConforMIS Inc., Geistlich Pharma AG, BioPoly LLC, Regen Lab SA, Octane Medical Group Inc., Orthocell Limited, Episurf Medical ABGlobal Knee Cartilage Repair Market Trends and Insights
Major companies operating in the knee cartilage repair market are focusing on developing innovative products, such as knee cartilage repair implants, to gain a competitive edge in the market. Knee cartilage repair implants are medical devices used in orthopedic surgery to facilitate the repair and regeneration of damaged knee cartilage. For instance, in March 2024, UC Davis Health, a US-based medical center, launched the MISHA Knee System, a knee cartilage repair implant to aid in knee cartilage repair. The MISHA Knee System is a resorbable device that helps regenerate cartilage in the knee. The implant stimulates the body's natural healing process, allowing new cartilage and bone tissue to grow and integrate with the implant over time.What Are Latest Mergers And Acquisitions In The Knee Cartilage Repair Market?
In January 2024, Smith & Nephew plc, a UK-based medical equipment company, acquired CartiHeal Ltd. for $180 million. With this acquisition, Smith & Nephew aligns its strategy to invest in its successful sports medicine business and enhance its knee repair portfolio, aiming to transform cartilage repair outcomes. CartiHeal Ltd. is a US-based medical device company providing novel knee cartilage repair technology.Regional Outlook
North America was the largest region in the knee cartilage repair market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Knee Cartilage Repair Market?
The knee cartilage repair market consists of revenues earned by entities by providing services such as stem cell therapy, physical therapy, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The knee cartilage repair market also includes sales of autologous chondrocyte implantation kits, osteochondral graft transplantation materials, non-steroidal anti-inflammatory medications, and fixation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Knee Cartilage Repair Market Report 2026?
The knee cartilage repair market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the knee cartilage repair industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Knee Cartilage Repair Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.31 billion |
| Revenue Forecast In 2035 | $4.16 billion |
| Growth Rate | CAGR of 6.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Device Type, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Stryker Corporation, B. Braun Melsungen AG, DePuy Synthes, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Integra LifeSciences, Bioventus LLC, MTF Biologics, MiMedx Group Inc., Moximed Inc., Vericel Corporation, Anika Therapeutics Inc., SeaSpine Holdings Corporation, LifeNet Health, ConforMIS Inc., Geistlich Pharma AG, BioPoly LLC, Regen Lab SA, Octane Medical Group Inc., Orthocell Limited, Episurf Medical AB |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
